GHRS
GH Research
North American company
Right Arrow 1
Healthcare
Right Arrow 2
Biotechnology
Prev. Close
/
Mkt. Open
- / -
Volume
-
52w Low / High
- / -
Market Cap
-
P/E Ratio
-
Div. Yield
-
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XNAS
-
Updated: -
Research
News & analysis
Loading...
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
Prev. Close
/
Mkt. Open
- / -
Volume
-
52w Low / High
- / -
Market Cap
-
P/E Ratio
-
Div. Yield
-
Company Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
Symbol
NASDAQ:GHRS
ISIN
IE000GID8VI0
Currency
USD
Loading...
Loading Comparison
Latest GHRS News